diclofenac has been researched along with cumene hydroperoxide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Crespi, CL; Miller, VP | 1 |
| Borgiani, P; Falconi, M; Ingelman-Sundberg, M; Johansson, I; Lee, MY; Mkrtchian, S; Oteri, F | 1 |
1 review(s) available for diclofenac and cumene hydroperoxide
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
2 other study(ies) available for diclofenac and cumene hydroperoxide
| Article | Year |
|---|---|
The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase.
Topics: Alleles; Aryl Hydrocarbon Hydroxylases; Benzene Derivatives; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Diclofenac; Humans; In Vitro Techniques; Kinetics; Lauric Acids; Lymphocytes; Microsomes; Microsomes, Liver; Mixed Function Oxygenases; NADPH-Ferrihemoprotein Reductase; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases | 1997 |
High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase.
Topics: Anticoagulants; Benzene Derivatives; Cells, Cultured; Cytochrome P-450 CYP2C9; Diclofenac; Heterozygote; Humans; Hydroxylation; NADP; NADPH-Ferrihemoprotein Reductase; Warfarin | 2014 |